In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Centene, with a price target of $45.00. The company’s shares closed last Friday at $28.39. Take advantage of ...

The S&P 500 was little changed on Monday, July 28, 2025, as investors absorbed the U.S.-EU trade deal and braced for this ...

Shares of health coverage company Centene (NYSE:CNC) fell 3% in the morning session after the company was downgraded by ...

Fintel reports that on July 28, 2025, Cantor Fitzgerald downgraded their outlook for Centene (NYSE:CNC) from Overweight to ...

CNC has offered FY2025 adj EPS range at between $1.25 (-82.5% YoY) and $1.75 (-75.5% YoY), as medical costs rise drastically ...

This downturn is primarily attributed to a continued increase in medical costs for government-backed insurance plans, ...

UnitedHealth faces regulatory scrutiny, fraud allegations, and leadership turmoil. Click here to learn why UNH stock is a ...

In its second quarter, the Clayton-based company lost $253 million dollars, 51 cents a share. In the same period last year, ...

Shares of health coverage company Centene (NYSE:CNC) jumped 5.9% in the afternoon session after the company reported ...

Centene represents a countercyclical investment opportunity in managed care, as it can benefit from economic downturns through increasing enrollment in its Medicaid and individual exchange products.

On the post-earnings call with analysts, Chief Executive Sarah London said the current forecast for 2025 adjusted earnings per share, which excludes nonrecurring items, was $1.75. That was down from ...

Centene reported a Q2 loss and pulled its 2025 guidance despite rising revenue, citing higher healthcare costs and shifting ...